Global Iguratimod Market Growth 2025-2031

December 2025 | 83 pages | ID: GFE87E6CAC5EN
LP Information

Abstracts

The global Iguratimod market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.

The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.

United States market for Iguratimod is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Iguratimod is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Iguratimod is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Iguratimod players cover Simcere Pharmaceutical, Toyama Chemical, Eisai, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LP Information, Inc. (LPI) ' newest research report, the “Iguratimod Industry Forecast” looks at past sales and reviews total world Iguratimod sales in 2024, providing a comprehensive analysis by region and market sector of projected Iguratimod sales for 2025 through 2031. With Iguratimod sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Iguratimod industry.

This Insight Report provides a comprehensive analysis of the global Iguratimod landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Iguratimod portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Iguratimod market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Iguratimod and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Iguratimod.

This report presents a comprehensive overview, market shares, and growth opportunities of Iguratimod market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:

• 14 Pcs/Box
• 100 Pcs/Box

Segmentation by Application:

• Antirheumatic
• Immunoregulation
• Others

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.

• Simcere Pharmaceutical
• Toyama Chemical
• Eisai

Key Questions Addressed in this Report

What is the 10-year outlook for the global Iguratimod market?

What factors are driving Iguratimod market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Iguratimod market opportunities vary by end market size?

How does Iguratimod break out by Type, by Application?

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Iguratimod Annual Sales 2020-2031
  2.1.2 World Current & Future Analysis for Iguratimod by Geographic Region, 2020, 2024 & 2031
  2.1.3 World Current & Future Analysis for Iguratimod by Country/Region, 2020, 2024 & 2031
2.2 Iguratimod Segment by Type
  2.2.1 14 Pcs/Box
  2.2.2 100 Pcs/Box
2.3 Iguratimod Sales by Type
  2.3.1 Global Iguratimod Sales Market Share by Type (2020-2025)
  2.3.2 Global Iguratimod Revenue and Market Share by Type (2020-2025)
  2.3.3 Global Iguratimod Sale Price by Type (2020-2025)
2.4 Iguratimod Segment by Application
  2.4.1 Antirheumatic
  2.4.2 Immunoregulation
  2.4.3 Others
2.5 Iguratimod Sales by Application
  2.5.1 Global Iguratimod Sale Market Share by Application (2020-2025)
  2.5.2 Global Iguratimod Revenue and Market Share by Application (2020-2025)
  2.5.3 Global Iguratimod Sale Price by Application (2020-2025)

3 GLOBAL BY COMPANY

3.1 Global Iguratimod Breakdown Data by Company
  3.1.1 Global Iguratimod Annual Sales by Company (2020-2025)
  3.1.2 Global Iguratimod Sales Market Share by Company (2020-2025)
3.2 Global Iguratimod Annual Revenue by Company (2020-2025)
  3.2.1 Global Iguratimod Revenue by Company (2020-2025)
  3.2.2 Global Iguratimod Revenue Market Share by Company (2020-2025)
3.3 Global Iguratimod Sale Price by Company
3.4 Key Manufacturers Iguratimod Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Iguratimod Product Location Distribution
  3.4.2 Players Iguratimod Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy

4 WORLD HISTORIC REVIEW FOR IGURATIMOD BY GEOGRAPHIC REGION

4.1 World Historic Iguratimod Market Size by Geographic Region (2020-2025)
  4.1.1 Global Iguratimod Annual Sales by Geographic Region (2020-2025)
  4.1.2 Global Iguratimod Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Iguratimod Market Size by Country/Region (2020-2025)
  4.2.1 Global Iguratimod Annual Sales by Country/Region (2020-2025)
  4.2.2 Global Iguratimod Annual Revenue by Country/Region (2020-2025)
4.3 Americas Iguratimod Sales Growth
4.4 APAC Iguratimod Sales Growth
4.5 Europe Iguratimod Sales Growth
4.6 Middle East & Africa Iguratimod Sales Growth

5 AMERICAS

5.1 Americas Iguratimod Sales by Country
  5.1.1 Americas Iguratimod Sales by Country (2020-2025)
  5.1.2 Americas Iguratimod Revenue by Country (2020-2025)
5.2 Americas Iguratimod Sales by Type (2020-2025)
5.3 Americas Iguratimod Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Iguratimod Sales by Region
  6.1.1 APAC Iguratimod Sales by Region (2020-2025)
  6.1.2 APAC Iguratimod Revenue by Region (2020-2025)
6.2 APAC Iguratimod Sales by Type (2020-2025)
6.3 APAC Iguratimod Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Iguratimod by Country
  7.1.1 Europe Iguratimod Sales by Country (2020-2025)
  7.1.2 Europe Iguratimod Revenue by Country (2020-2025)
7.2 Europe Iguratimod Sales by Type (2020-2025)
7.3 Europe Iguratimod Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Iguratimod by Country
  8.1.1 Middle East & Africa Iguratimod Sales by Country (2020-2025)
  8.1.2 Middle East & Africa Iguratimod Revenue by Country (2020-2025)
8.2 Middle East & Africa Iguratimod Sales by Type (2020-2025)
8.3 Middle East & Africa Iguratimod Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Iguratimod
10.3 Manufacturing Process Analysis of Iguratimod
10.4 Industry Chain Structure of Iguratimod

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Iguratimod Distributors
11.3 Iguratimod Customer

12 WORLD FORECAST REVIEW FOR IGURATIMOD BY GEOGRAPHIC REGION

12.1 Global Iguratimod Market Size Forecast by Region
  12.1.1 Global Iguratimod Forecast by Region (2026-2031)
  12.1.2 Global Iguratimod Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Iguratimod Forecast by Type (2026-2031)
12.7 Global Iguratimod Forecast by Application (2026-2031)

13 KEY PLAYERS ANALYSIS

13.1 Simcere Pharmaceutical
  13.1.1 Simcere Pharmaceutical Company Information
  13.1.2 Simcere Pharmaceutical Iguratimod Product Portfolios and Specifications
  13.1.3 Simcere Pharmaceutical Iguratimod Sales, Revenue, Price and Gross Margin (2020-2025)
  13.1.4 Simcere Pharmaceutical Main Business Overview
  13.1.5 Simcere Pharmaceutical Latest Developments
13.2 Toyama Chemical
  13.2.1 Toyama Chemical Company Information
  13.2.2 Toyama Chemical Iguratimod Product Portfolios and Specifications
  13.2.3 Toyama Chemical Iguratimod Sales, Revenue, Price and Gross Margin (2020-2025)
  13.2.4 Toyama Chemical Main Business Overview
  13.2.5 Toyama Chemical Latest Developments
13.3 Eisai
  13.3.1 Eisai Company Information
  13.3.2 Eisai Iguratimod Product Portfolios and Specifications
  13.3.3 Eisai Iguratimod Sales, Revenue, Price and Gross Margin (2020-2025)
  13.3.4 Eisai Main Business Overview
  13.3.5 Eisai Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Iguratimod Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Iguratimod Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of 14 Pcs/Box
Table 4. Major Players of 100 Pcs/Box
Table 5. Global Iguratimod Sales by Type (2020-2025) & (K Pcs)
Table 6. Global Iguratimod Sales Market Share by Type (2020-2025)
Table 7. Global Iguratimod Revenue by Type (2020-2025) & ($ million)
Table 8. Global Iguratimod Revenue Market Share by Type (2020-2025)
Table 9. Global Iguratimod Sale Price by Type (2020-2025) & (USD/Pcs)
Table 10. Global Iguratimod Sale by Application (2020-2025) & (K Pcs)
Table 11. Global Iguratimod Sale Market Share by Application (2020-2025)
Table 12. Global Iguratimod Revenue by Application (2020-2025) & ($ million)
Table 13. Global Iguratimod Revenue Market Share by Application (2020-2025)
Table 14. Global Iguratimod Sale Price by Application (2020-2025) & (USD/Pcs)
Table 15. Global Iguratimod Sales by Company (2020-2025) & (K Pcs)
Table 16. Global Iguratimod Sales Market Share by Company (2020-2025)
Table 17. Global Iguratimod Revenue by Company (2020-2025) & ($ millions)
Table 18. Global Iguratimod Revenue Market Share by Company (2020-2025)
Table 19. Global Iguratimod Sale Price by Company (2020-2025) & (USD/Pcs)
Table 20. Key Manufacturers Iguratimod Producing Area Distribution and Sales Area
Table 21. Players Iguratimod Products Offered
Table 22. Iguratimod Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Iguratimod Sales by Geographic Region (2020-2025) & (K Pcs)
Table 26. Global Iguratimod Sales Market Share Geographic Region (2020-2025)
Table 27. Global Iguratimod Revenue by Geographic Region (2020-2025) & ($ millions)
Table 28. Global Iguratimod Revenue Market Share by Geographic Region (2020-2025)
Table 29. Global Iguratimod Sales by Country/Region (2020-2025) & (K Pcs)
Table 30. Global Iguratimod Sales Market Share by Country/Region (2020-2025)
Table 31. Global Iguratimod Revenue by Country/Region (2020-2025) & ($ millions)
Table 32. Global Iguratimod Revenue Market Share by Country/Region (2020-2025)
Table 33. Americas Iguratimod Sales by Country (2020-2025) & (K Pcs)
Table 34. Americas Iguratimod Sales Market Share by Country (2020-2025)
Table 35. Americas Iguratimod Revenue by Country (2020-2025) & ($ millions)
Table 36. Americas Iguratimod Sales by Type (2020-2025) & (K Pcs)
Table 37. Americas Iguratimod Sales by Application (2020-2025) & (K Pcs)
Table 38. APAC Iguratimod Sales by Region (2020-2025) & (K Pcs)
Table 39. APAC Iguratimod Sales Market Share by Region (2020-2025)
Table 40. APAC Iguratimod Revenue by Region (2020-2025) & ($ millions)
Table 41. APAC Iguratimod Sales by Type (2020-2025) & (K Pcs)
Table 42. APAC Iguratimod Sales by Application (2020-2025) & (K Pcs)
Table 43. Europe Iguratimod Sales by Country (2020-2025) & (K Pcs)
Table 44. Europe Iguratimod Revenue by Country (2020-2025) & ($ millions)
Table 45. Europe Iguratimod Sales by Type (2020-2025) & (K Pcs)
Table 46. Europe Iguratimod Sales by Application (2020-2025) & (K Pcs)
Table 47. Middle East & Africa Iguratimod Sales by Country (2020-2025) & (K Pcs)
Table 48. Middle East & Africa Iguratimod Revenue Market Share by Country (2020-2025)
Table 49. Middle East & Africa Iguratimod Sales by Type (2020-2025) & (K Pcs)
Table 50. Middle East & Africa Iguratimod Sales by Application (2020-2025) & (K Pcs)
Table 51. Key Market Drivers & Growth Opportunities of Iguratimod
Table 52. Key Market Challenges & Risks of Iguratimod
Table 53. Key Industry Trends of Iguratimod
Table 54. Iguratimod Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Iguratimod Distributors List
Table 57. Iguratimod Customer List
Table 58. Global Iguratimod Sales Forecast by Region (2026-2031) & (K Pcs)
Table 59. Global Iguratimod Revenue Forecast by Region (2026-2031) & ($ millions)
Table 60. Americas Iguratimod Sales Forecast by Country (2026-2031) & (K Pcs)
Table 61. Americas Iguratimod Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 62. APAC Iguratimod Sales Forecast by Region (2026-2031) & (K Pcs)
Table 63. APAC Iguratimod Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 64. Europe Iguratimod Sales Forecast by Country (2026-2031) & (K Pcs)
Table 65. Europe Iguratimod Revenue Forecast by Country (2026-2031) & ($ millions)
Table 66. Middle East & Africa Iguratimod Sales Forecast by Country (2026-2031) & (K Pcs)
Table 67. Middle East & Africa Iguratimod Revenue Forecast by Country (2026-2031) & ($ millions)
Table 68. Global Iguratimod Sales Forecast by Type (2026-2031) & (K Pcs)
Table 69. Global Iguratimod Revenue Forecast by Type (2026-2031) & ($ millions)
Table 70. Global Iguratimod Sales Forecast by Application (2026-2031) & (K Pcs)
Table 71. Global Iguratimod Revenue Forecast by Application (2026-2031) & ($ millions)
Table 72. Simcere Pharmaceutical Basic Information, Iguratimod Manufacturing Base, Sales Area and Its Competitors
Table 73. Simcere Pharmaceutical Iguratimod Product Portfolios and Specifications
Table 74. Simcere Pharmaceutical Iguratimod Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 75. Simcere Pharmaceutical Main Business
Table 76. Simcere Pharmaceutical Latest Developments
Table 77. Toyama Chemical Basic Information, Iguratimod Manufacturing Base, Sales Area and Its Competitors
Table 78. Toyama Chemical Iguratimod Product Portfolios and Specifications
Table 79. Toyama Chemical Iguratimod Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 80. Toyama Chemical Main Business
Table 81. Toyama Chemical Latest Developments
Table 82. Eisai Basic Information, Iguratimod Manufacturing Base, Sales Area and Its Competitors
Table 83. Eisai Iguratimod Product Portfolios and Specifications
Table 84. Eisai Iguratimod Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 85. Eisai Main Business
Table 86. Eisai Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Picture of Iguratimod
Figure 2. Iguratimod Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Iguratimod Sales Growth Rate 2020-2031 (K Pcs)
Figure 7. Global Iguratimod Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Iguratimod Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Iguratimod Sales Market Share by Country/Region (2024)
Figure 10. Iguratimod Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of 14 Pcs/Box
Figure 12. Product Picture of 100 Pcs/Box
Figure 13. Global Iguratimod Sales Market Share by Type in 2025
Figure 14. Global Iguratimod Revenue Market Share by Type (2020-2025)
Figure 15. Iguratimod Consumed in Antirheumatic
Figure 16. Global Iguratimod Market: Antirheumatic (2020-2025) & (K Pcs)
Figure 17. Iguratimod Consumed in Immunoregulation
Figure 18. Global Iguratimod Market: Immunoregulation (2020-2025) & (K Pcs)
Figure 19. Iguratimod Consumed in Others
Figure 20. Global Iguratimod Market: Others (2020-2025) & (K Pcs)
Figure 21. Global Iguratimod Sale Market Share by Application (2024)
Figure 22. Global Iguratimod Revenue Market Share by Application in 2025
Figure 23. Iguratimod Sales by Company in 2025 (K Pcs)
Figure 24. Global Iguratimod Sales Market Share by Company in 2025
Figure 25. Iguratimod Revenue by Company in 2025 ($ millions)
Figure 26. Global Iguratimod Revenue Market Share by Company in 2025
Figure 27. Global Iguratimod Sales Market Share by Geographic Region (2020-2025)
Figure 28. Global Iguratimod Revenue Market Share by Geographic Region in 2025
Figure 29. Americas Iguratimod Sales 2020-2025 (K Pcs)
Figure 30. Americas Iguratimod Revenue 2020-2025 ($ millions)
Figure 31. APAC Iguratimod Sales 2020-2025 (K Pcs)
Figure 32. APAC Iguratimod Revenue 2020-2025 ($ millions)
Figure 33. Europe Iguratimod Sales 2020-2025 (K Pcs)
Figure 34. Europe Iguratimod Revenue 2020-2025 ($ millions)
Figure 35. Middle East & Africa Iguratimod Sales 2020-2025 (K Pcs)
Figure 36. Middle East & Africa Iguratimod Revenue 2020-2025 ($ millions)
Figure 37. Americas Iguratimod Sales Market Share by Country in 2025
Figure 38. Americas Iguratimod Revenue Market Share by Country (2020-2025)
Figure 39. Americas Iguratimod Sales Market Share by Type (2020-2025)
Figure 40. Americas Iguratimod Sales Market Share by Application (2020-2025)
Figure 41. United States Iguratimod Revenue Growth 2020-2025 ($ millions)
Figure 42. Canada Iguratimod Revenue Growth 2020-2025 ($ millions)
Figure 43. Mexico Iguratimod Revenue Growth 2020-2025 ($ millions)
Figure 44. Brazil Iguratimod Revenue Growth 2020-2025 ($ millions)
Figure 45. APAC Iguratimod Sales Market Share by Region in 2025
Figure 46. APAC Iguratimod Revenue Market Share by Region (2020-2025)
Figure 47. APAC Iguratimod Sales Market Share by Type (2020-2025)
Figure 48. APAC Iguratimod Sales Market Share by Application (2020-2025)
Figure 49. China Iguratimod Revenue Growth 2020-2025 ($ millions)
Figure 50. Japan Iguratimod Revenue Growth 2020-2025 ($ millions)
Figure 51. South Korea Iguratimod Revenue Growth 2020-2025 ($ millions)
Figure 52. Southeast Asia Iguratimod Revenue Growth 2020-2025 ($ millions)
Figure 53. India Iguratimod Revenue Growth 2020-2025 ($ millions)
Figure 54. Australia Iguratimod Revenue Growth 2020-2025 ($ millions)
Figure 55. China Taiwan Iguratimod Revenue Growth 2020-2025 ($ millions)
Figure 56. Europe Iguratimod Sales Market Share by Country in 2025
Figure 57. Europe Iguratimod Revenue Market Share by Country (2020-2025)
Figure 58. Europe Iguratimod Sales Market Share by Type (2020-2025)
Figure 59. Europe Iguratimod Sales Market Share by Application (2020-2025)
Figure 60. Germany Iguratimod Revenue Growth 2020-2025 ($ millions)
Figure 61. France Iguratimod Revenue Growth 2020-2025 ($ millions)
Figure 62. UK Iguratimod Revenue Growth 2020-2025 ($ millions)
Figure 63. Italy Iguratimod Revenue Growth 2020-2025 ($ millions)
Figure 64. Russia Iguratimod Revenue Growth 2020-2025 ($ millions)
Figure 65. Middle East & Africa Iguratimod Sales Market Share by Country (2020-2025)
Figure 66. Middle East & Africa Iguratimod Sales Market Share by Type (2020-2025)
Figure 67. Middle East & Africa Iguratimod Sales Market Share by Application (2020-2025)
Figure 68. Egypt Iguratimod Revenue Growth 2020-2025 ($ millions)
Figure 69. South Africa Iguratimod Revenue Growth 2020-2025 ($ millions)
Figure 70. Israel Iguratimod Revenue Growth 2020-2025 ($ millions)
Figure 71. Turkey Iguratimod Revenue Growth 2020-2025 ($ millions)
Figure 72. GCC Countries Iguratimod Revenue Growth 2020-2025 ($ millions)
Figure 73. Manufacturing Cost Structure Analysis of Iguratimod in 2025
Figure 74. Manufacturing Process Analysis of Iguratimod
Figure 75. Industry Chain Structure of Iguratimod
Figure 76. Channels of Distribution
Figure 77. Global Iguratimod Sales Market Forecast by Region (2026-2031)
Figure 78. Global Iguratimod Revenue Market Share Forecast by Region (2026-2031)
Figure 79. Global Iguratimod Sales Market Share Forecast by Type (2026-2031)
Figure 80. Global Iguratimod Revenue Market Share Forecast by Type (2026-2031)
Figure 81. Global Iguratimod Sales Market Share Forecast by Application (2026-2031)
Figure 82. Global Iguratimod Revenue Market Share Forecast by Application (2026-2031)